Shilpa Pharma Lifesciences Passes Second Consecutive FDA Inspection with No Observations

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Admin...

April 10, 2025 | Thursday | News
South Korea Makes History with World’s First Recombinant Anthrax Vaccine Approval

GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly develop...

April 09, 2025 | Wednesday | News
Innocan Pharma Advances Global Patent Strategy with Divisional Application for Liposome-Based CBD Technology in China

 Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for it...

April 08, 2025 | Tuesday | News
AES Cleanroom Technology Launches Omni ASCENT at INTERPHEX 2025 to Redefine Modular Utility Integration

AES Cleanroom Technology, a leader in modular cleanroom solutions, has officially launched Omni ASCENT at INTERPHEX 2025. The next-generation Off-Site Ma...

April 04, 2025 | Friday | News
Thermo Fisher Scientific Launches Krios 5 Cryo-TEM Revolutionizing Structural Biology with Enhanced Throughput and AI Automation

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generati...

April 03, 2025 | Thursday | News
Cytiva Expands MabSelect Resin Portfolio to Advance Affordable and Scalable mAb Purification

  MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva's expanded resin portfolio will ...

April 03, 2025 | Thursday | News
DuPont Launches Liveo™ Pharma TPE Ultra-Low Temp Tubing for Demanding Biopharma Processing Needs

  Sterilizable, weldable, sealable thermoplastic elastomer tubing intended for biopharmaceutical processing applications that require low temperature...

April 03, 2025 | Thursday | News
Lonza Launches New Operating Model to Power ‘One Lonza’ Vision and Streamline CDMO Business

Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy Previous divisional structure ...

April 02, 2025 | Wednesday | News
Hoth Therapeutics Receives USPTO Filing Receipt for New Patent on HT-001 Formulation

 Hoth Therapeutics, Inc. , a patient-focused clinical-stage biopharmaceutical company, announced that it has received an official Filing Rec...

April 01, 2025 | Tuesday | News
Akeso Advances Global Leadership in Bispecific Antibodies with Approvals for Ivonescimab and Cadonilimab

Akeso Inc. (9926.HK), a leading biopharmaceutical company, has announced major advancements in its antibody drug pipeline, underscoring a transformative ...

March 31, 2025 | Monday | News
Cytiva Expands Xcellerex X-Platform Bioreactor Portfolio to Accelerate Advanced Therapeutics

    X-platform bioreactors are designed to help navigate challenges by combining reliability, scalability, and flexibility in one solution&...

March 26, 2025 | Wednesday | News
SK pharmteco Embarks on My Green Lab Certification to Advance Sustainable Laboratory Practices

-SK pharmteco, a global pharmaceutical subcontract development and manufacturing organization, CDMO), has just reached an important step in its sustainab...

March 14, 2025 | Friday | News
Polyrizon Signs LOI to Develop Intranasal Psychedelic-Based Therapeutics

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development...

March 14, 2025 | Friday | News
Rivus Pharmaceuticals Announces Positive Phase 2a HuMAIN Trial Results for HU6 in Obesity-Related Heart Failure with Preserved Ejection Fraction

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity, announced the pub...

March 13, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close